Dsg2tm1d(EUCOMM)Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Dsg2tm1d(EUCOMM)Wtsi |
| Name: |
desmoglein 2; targeted mutation 1d, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:6501716 |
| Synonyms: |
Dsg2mut |
| Gene: |
Dsg2 Location: Chr18:20691247-20737583 bp, + strand Genetic Position: Chr18, 11.42 cM
|
| Alliance: |
Dsg2tm1d(EUCOMM)Wtsi page
|
|
| Germline Transmission: |
Earliest citation of germline transmission:
J:235770
|
| Parent Cell Line: |
JM8.N4 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutations: |
|
Insertion, Intragenic deletion
|
| |
|
Mutation details: The L1L2_Bact_P cassette was inserted at position 20711672 of Chromosome 18 upstream of the critical exon(s) (Build GRCm39). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site. A third loxP site is inserted downstream of the targeted exon(s) at position 20712812. The critical exons 4 and 5 are thus flanked by loxP sites. Flp-mediated recombination removed the lacZ and neomycin resistance gene and subsequent cre expression deleted exons 4 and 5. Exon 4 and 5 deletion causes a frameshift mutation and premature termination of translation.
(J:235770)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
|
|
| Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
| Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
| Carrying any Dsg2 Mutation: |
84 strains or lines available
|
|
| Original: |
J:235770 Chelko SP, et al., Central role for GSK3beta in the pathogenesis of arrhythmogenic cardiomyopathy. JCI Insight. 2016 Apr 21;1(5) |
| All: |
4 reference(s) |
|